Breaking News
September 25, 2018 - Researchers analyze response to combination immunotherapy for patients with rare skin cancer
September 25, 2018 - Study sheds light on how brain protein may be involved neurodevelopmental disorders
September 25, 2018 - Where to draw the line on incentives
September 25, 2018 - Solid fuel use linked with increased risk of hospitalization or death from respiratory diseases
September 25, 2018 - Recurrence risk of VTE appears similar for patients with cancer and those with unprovoked VTE
September 25, 2018 - Global leaders must make bold commitments at first-ever UN tuberculosis summit
September 25, 2018 - Brief sleep intervention works long-term to prevent child obesity
September 25, 2018 - Vaping among kids and teens a growing concern
September 25, 2018 - Public launch of products and application solutions from Porvair Laboratory Division
September 25, 2018 - Harmful H. pylori may play a role in Parkinson’s disease
September 25, 2018 - Researchers develop way to measure different types of fear of falling in patients with Parkinson’s
September 25, 2018 - Fracture causes bone density losses throughout the body
September 25, 2018 - Researchers highlight potential therapy for treating rare, deadly blood-clotting disorder
September 25, 2018 - Hybrid theranostic complex shows high therapeutic efficacy against tumor cells
September 25, 2018 - FDA Issues Statement Reaffirming the Positive Benefit-Risk Profile of Nuplazid (pimavanserin) for Patients with Hallucinations and Delusions Associated with Parkinson’s Disease Psychosis
September 25, 2018 - Toxicological evaluation and dosimetry estimation of potential PET radiotracer
September 25, 2018 - 5 obstacles parents commonly face in child obesity treatment and how to overcome them
September 25, 2018 - Immunologist to study how Chikungunya causes devastating effects in older adults
September 25, 2018 - Rural borderland communities vulnerable to high stress impacting mental and physical health
September 25, 2018 - SNMMI announces recipients of 2018-2020 Wagner-Torizuka Fellowship
September 25, 2018 - Common painkiller not effective in controlling chronic pain after traumatic nerve injury
September 25, 2018 - New therapeutic vaccine helps immune cells fight HPV-related head and neck cancer
September 25, 2018 - Environmentally-induced gene activity influences IQ test performance
September 25, 2018 - Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI
September 25, 2018 - FDA Approves Copiktra (duvelisib) Capsules for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Follicular Lymphoma
September 25, 2018 - Medical device company settles US case over false claims
September 25, 2018 - Trying to get answers: One woman’s quest for a diagnosis
September 25, 2018 - Lung cancer patients treated with invasive surgery more likely to become chronic opioid users
September 25, 2018 - Oxford VR raises £3.2m to boost innovation in VR for mental health problems
September 25, 2018 - Gene therapy approach could help treat mitochondrial diseases
September 25, 2018 - Few Yogurt Products Qualify As Low-Sugar
September 25, 2018 - Eye disease can cause blindness, and it’s on the rise
September 25, 2018 - Pawnshop density linked to gun-related suicides, Stanford study finds
September 25, 2018 - Pioneering procedure for common prostate condition offered by The London Clinic
September 25, 2018 - Number of people with respiratory diseases likely to increase if UK air pollution remains unchecked
September 25, 2018 - FARXIGA receives positive results in Phase III DECLARE-TIMI 58 cardiovascular outcomes trial
September 25, 2018 - New program to reduce harmful stress effectively improves mood in cancer patients
September 24, 2018 - Florence’s Lingering Threat: Mold – Drugs.com MedNews
September 24, 2018 - For professional baseball players, faster hand-eye coordination linked to batting performance
September 24, 2018 - Bill for later school start times is defeated, but Stanford sleep specialist isn’t
September 24, 2018 - For Heart Failure Patients, Mitral Valve Procedure Improved Outcomes
September 24, 2018 - Successful recovery from addiction means more than achieving abstinence
September 24, 2018 - New nanoplatform technology may reverse drug-resistance in renal cell carcinoma
September 24, 2018 - October 1918 marks the centenary of Spanish Flu that claimed more lives than World War I
September 24, 2018 - LGBT community reports more number of poor mental health days than general population
September 24, 2018 - New research suggests power of zebrafish as tool for cancer drug discovery
September 24, 2018 - New study finds height as possible risk factor for developing varicose veins
September 24, 2018 - Researchers compare weight loss results of online and in-person diabetes prevention program
September 24, 2018 - New HER2 PET Study Uses Affibody’s ABY-025 Tracer to Individualize Breast Cancer Treatment
September 24, 2018 - Drug combination offers more effective care for patients suffering miscarriage
September 24, 2018 - Tallness linked to varicose veins, Stanford study says
September 24, 2018 - For Heart Failure Patients, Mitral Valve Procedure Improved Outcomes
September 24, 2018 - Ecstasy drug makes octopuses more social
September 24, 2018 - Immediate compression therapy could cut risk of complications after deep-vein thrombosis
September 24, 2018 - Transcatheter mitral valve repair reduces mortality for patients with mitral regurgitation
September 24, 2018 - First intracranial aneurysm patients treated with BRAVO Flow Diverter after CE mark approval
September 24, 2018 - ‘Physicians of the mouth’? Dentists absorb the medical billing drill
September 24, 2018 - People more likely to believe those with confident tone of voice than with accent
September 24, 2018 - Harmony Biosciences Presents 5-Year Data On Pitolisant At International Narcolepsy Symposium
September 24, 2018 - Blood test may identify gestational diabetes risk in first trimester
September 24, 2018 - Height may be risk factor for varicose veins | News Center
September 24, 2018 - King’s commemorates opening of new NMR facility with one-day symposium
September 24, 2018 - Eisai receives approval for partial label change of DC Bead device for transcatheter arterial embolization
September 24, 2018 - Using multi-level approach to reduce underage drinking among youths on rural reservations
September 24, 2018 - High-resolution genomic map gives scientists unprecedented view of brain development
September 24, 2018 - Researchers find impact of neurobehavioral symptoms on employment in adults with TBI
September 24, 2018 - Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD
September 24, 2018 - First evaluation of benefits, harms of Alzheimer’s screening for family members of older adults
September 24, 2018 - Ancora Heart announces positive data of study evaluating AccuCinch Ventricular Repair System
September 24, 2018 - Children of mothers using cannabis may start using it at an earlier age, finds study
September 24, 2018 - Gilead Sciences plans to launch authorized generic versions of Epclusa and Harvoni in the US
September 24, 2018 - Most patients who underwent transcatheter valve replacement experience prosthesis-patient mismatch
September 24, 2018 - Lumos acquires license for LUM-201 drug that promotes secretion of growth hormone
September 24, 2018 - New study provides basis for Air Canada to change its facial hair policy for aircrew
September 24, 2018 - Infant walkers lead to thousands of emergency visits for babies
September 24, 2018 - Genes predicting person’s height may provide clues about causes of varicose veins
September 24, 2018 - EPA Plan Will Maintain Carbon Emissions From Power Plants
September 24, 2018 - Characterizing pig hippocampus could improve translational neuroscience
September 24, 2018 - Element3 Health reports social and mental engagement play key role in overall health
September 24, 2018 - Paralympic medalists support Fight for Sight’s unique virtual event

Drug-Resistant Bacteria: On the Edge of a Crisis

image_pdfDownload PDFimage_print

Drug-Resistant Bacteria: On the Edge of a Crisis

Photo: iStock

For the past 70 years, antimicrobial drugs, such as antibiotics, have successfully treated patients with infections. But over time, many infectious organisms have adapted to the drugs that kill them, making them less e ective. Overusing or misusing these drugs can make resistance develop even faster.

Each year in the U.S. at least 2 million people become infected with bacteria that are resistant to antibiotics. At least 23,000 people die annually as a direct result of these infections. Many more people die from complications of antibiotic-resistant infections.

To address this growing problem, the National Institute of Allergy and Infectious Diseases (NIAID) is working to speed the development of faster ways to detect resistance and ultimately to nd new treatments that are e ective against these drug-resistant bacteria.

Anthony S. Fauci, M.D., has been the director of the National Institute of Allergy and Infectious Diseases (NIAID) since 1984. He helped pioneer the field of human immunoregulation, or the control of specific immune responses and interactions. He has also advised five presidents and the U.S. Department of Health and Human Services on HIV/AIDS and many other health issues. He spoke to NIH MedlinePlus magazine to discuss NIAID’s drug-resistant bacteria research program.

Why are certain bacteria becoming more resistant to drugs?

There is a multi-part answer to that question. One of the most important reasons is that bacteria generally mutate—all microbes mutate—naturally and spontaneously. However, you can do things that pressure them to mutate even more and develop resistance to drugs.

Each year in the U.S., at least 2 million people become infected with bacteria that are resistant to antibiotics
– Centers for Disease Control and Prevention

One of the major factors in certain bacteria becoming resistant to drugs today is the overuse of antibiotics, particularly the inappropriate use of antibiotics. This includes using antibiotics when you do not really have to—either when you have a viral infection that you think is bacterial and treat it with an antibiotic, or you treat someone with the wrong antibiotic that is not particularly suited to the bacteria in question.

In other words, if you are given antibiotics, you will kill all the sensitive bacteria. Most of the ones that will survive will be the resistant ones.

You and other experts in the field have said that we are on the edge of a national, even global crisis of drug-resistant bacteria. Why is that?

The more we see this growing problem of antimicrobial resistance throughout the world, the more we will begin to see bacteria that are relatively untreatable or very, very difficult to treat. And if those bacteria become very widespread, that could lead to a serious crisis.

What might such a situation look like to most people?

A typical, real-life example would be someone gets a surgical procedure like a hip or knee replacement, or goes to the hospital for abdominal surgery. Then they get an infection that happens to come from another hospital patient who has resistant bacteria. What should be a routine procedure could lead to an infection that you struggle to treat, and you end up with a high degree of morbidity or even mortality. The routine surgical case becomes a medical emergency.

What kinds of antimicrobial-resistant bacteria are common in the U.S.?

We still have the problem of methicillin-resistant Staphylococcus aureus (MRSA), which is disturbing. Another one that is also disturbing is called Carbapenem-resistant Enterobacteriaceae, or CRE. That is a growing problem. We see that in hospital patients who are immunosuppressed as a result of, for example, transplants or drugs that suppress their cancer or their inflammatory disease. Another bacteria that causes infections when antibiotics are overused is Clostridium difficile (C. Difficile), which we see a lot of in nursing homes and hospital settings.

Those three are big ones—MRSA, CRE, and C. Difficile. And, depending on the population in question, globally we are seeing more and more resistance to gonorrhea, a sexually transmitted disease.

How is NIAID approaching research to help solve the challenges associated with antimicrobial resistance?

Our research spans a wide range of activities, starting with understanding the molecular basis of how bacterial resistance evolves.

The second thing we are doing is a molecular analysis of microbes to determine what the targets are for resistance and for new antibiotics. Another is to develop new, unique ways of combating bacteria, such as understanding how microbes survive in different environments and exploiting that to fight them.

We also spend a lot of time working with the pharmaceutical companies on concept development towards the ultimate development of new antibiotics. While new antibiotics will ultimately be made by pharmaceutical companies, NIH and NIAID have a basic, fundamental role in the clinical and applied research and development of these new antibiotics.

Tagged with:

About author

Related Articles